Supplementary Figure Legend from EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming
Remi Adelaiye‐Ogala(Roswell Park Comprehensive Cancer Center), Роберто Пили(Jacobs Institute), Scott A. Persohn(Indiana University Health), Nur P. Damayanti(University of Indianapolis), Janaiah Kota(Ultragenyx Pharmaceutical (United States)), Weiyang Tao, Sreenivasulu Chintala(UC San Diego Health System), Brian P. McCarthy(Indiana University Health), Giulio Draetta(The University of Texas MD Anderson Cancer Center), Michael Buck(University at Buffalo, State University of New York), Sreevani Arisa(Indiana University – Purdue University Indianapolis), Justin A. Budka(Gilead Sciences (United Kingdom)), Milan Radovich(Caris Life Sciences (United States)), Chuan‐Chih Hsu, Yong Zang(University of Science and Technology Beijing), Joseph Irudayaraj(Carle Foundation Hospital), May Elbanna(Indiana University Health), Paul R. Territo(Indiana University Health), Kiersten Marie Miles(Roswell Park Comprehensive Cancer Center), Piergiorgio Pettazzoni(Roche (Switzerland)), Heike Keilhack(Epizyme (United States)), Mary W. Ferris(Indiana University Bloomington), Justine Arrington(Purdue University West Lafayette), Eric Ciamporcero(Roswell Park Comprehensive Cancer Center), Mukund Seshadri(Roswell Park Comprehensive Cancer Center), Shen Li(University of Shanghai for Science and Technology), Bradley A. Hancock(Indiana University – Purdue University Indianapolis), Ashley Orillion(Roswell Park Comprehensive Cancer Center), Peter C. Hollenhorst(Indiana University Bloomington)
Cited by 0
Related Papers
Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27
|Science|1995|1.8k
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
|The Lancet Oncology|2018|614
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
|Genes & Development|1999|611